Medicare Enrolled

Dr. Richard Livernois, M.D.

Ophthalmology · Pensacola, FL
Low-engagement
5101 N DAVIS HWY, Pensacola, FL 32503
8504381277
In practice since 2006 (19 years)
NPI: 1578596466 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Livernois from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Livernois? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Livernois

Dr. Richard Livernois is an ophthalmology specialist in Pensacola, FL, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Livernois received a total of $6,108 from 25 pharmaceutical and/or device companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Livernois is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $6,108 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,108
Total received (2018-2024)
Avg $873/year across 7 years
Top 21% in FL for ophthalmology
25
Companies
80
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,030 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$78 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$408
2023
$144
2022
$1,151
2021
$1,011
2020
$187
2019
$2,694
2018
$513

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Johnson & Johnson Surgical Vision, Inc.
$3,137
EyePoint Pharmaceuticals US, Inc.
$398
Sun Pharmaceutical Industries Inc.
$379
Alcon Vision LLC
$200
Kala Pharmaceuticals, Inc.
$188
Sight Sciences, Inc.
$174
RxSight Inc
$163
Allergan, Inc.
$161
Bausch & Lomb, a division of Bausch Health US, LLC
$146
Glaukos Corporation
$146
BIOTISSUE HOLDINGS, INC.
$144
Carl Zeiss Meditec USA, Inc.
$128
Allergan Inc.
$117
Novartis Pharmaceuticals Corporation
$113
Carl Zeiss Meditec, Inc.
$110
Horizon Therapeutics plc
$103
TOPCON MEDICAL SYSTEMS, INC.
$86
Katena Products, Inc.
$48
Carl Zeiss Meditec AG
$39
Shire North American Group Inc
$34
ABBVIE INC.
$30
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Johnson & Johnson Vision Care, Inc.
$16
Dompe US, Inc.
$16
Oyster Point Pharma, Inc.
$15
Top 3 companies account for 64.1% of total payments
Associated products mentioned in payments ›
AcrySof IQ PanOptix · Acuvue · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CLARUS · CRYSTALENS · Catalys Laser System · Cequa · DEXYCU · EYSUVIS · INVELTYS · KXL System · None Specified · OCT TRITON · OXERVATE · Ophthalmic Surgical Adjuncts · PROKERA · PanOptix · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · TECNIS IOL · TEPEZZA · TRULIGN TORIC · TYRVAYA · TearCare SmartLid · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Multifocal Family of 1-piece IOLS · Tecnis Simplicity · Tecnis Symfony IOL · VERITAS Vision System · VUITY · VYZULTA · VisuMax · XIIDRA · YUTIQ · iFS Advanced Femtosecond Laser
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Pensacola?
Compare ophthalmologists in the Pensacola area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
32
Per 100K population
9.9
County median income
$65,715
Nearest hospital
BAPTIST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Livernois is an ophthalmology specialist, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Livernois receive payments from pharmaceutical companies?
Yes. Dr. Livernois received a total of $6,108 from 25 companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Livernois) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →